The value of CRP and NLR in differential diagnosis of benign and malignant pulmonary nodules
Abstract
Objective: Evaluate CRP and NLR levels in benign vs. malignant pulmonary nodules for differential diagnosis. Methods: Selected 60 patients with benign nodules and 60 with lung cancer from a Hunan hospital from August 2022 to December 2023. Analyzed CRP and NLR diagnostic value. Results: Significant differences in CRP, NLR levels between groups (P<0.05). Conclusion: CRP and NLR levels are higher in lung cancer patients, indicating diagnostic value in distinguishing benign vs. malignant nodules.
References
[1] Bach PB, Mirkin JN, Oliver TK, et al. Benefts and harms of CT scrWalter K. Pulmonary Nodules. JAMA.2021 Oct
19;326(15):1544. doi: 10.1001/jama.2021.12319. PMID: 34665202.
[2] eening for lung cancer: a systematic review. JAMA, 2012, 307(22): 2418-2429. doi:10.1001/jama.2012.5521.
[3] Singh Rajesh,Mishra Manoj Kumar,Aggarwal Himanshu,Inflammation, Immunity, and Cancer.[J] .Mediators Inflamm, 2017, 2017:
6027305.
[4] Giese Morgan A,Hind Laurel E,Huttenlocher Anna,Neutrophil plasticity in the tumor microenvironment.[J] .Blood, 2019, 133:
2159-2167.
[5] Zhao Qing-Tao,Yuan Zheng,Zhang Hua et al. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.[J] .Int J Cancer, 2016, 139: 164-70.
[6] Colotta Francesco,Allavena Paola,Sica Antonio et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic
instability.[J] .Carcinogenesis, 2009, 30: 1073-81.
[7] Budisan Liviuta,Zanoaga Oana,Braicu Cornelia et al. Links between Infections, Lung Cancer, and the Immune System.[J] .Int J
Mol Sci, 2021, 22: undefined.
[8] Chen C, Liu JN, Zhao JQ, Zang B. C-reactive protein gene 1846C>T polymorphism is associated with increased risk and clinical
features of lung cancer: a case-control study. Biosci Rep. 2019 Jun 20;39(6):BSR20181936.
[9] Wu Zhenyong. Diagnostic Value of MicroRNA (miRNA) Combined with C-Reactive Protein Detection in Early Lung Cancer [J].
Journal of Practical Oncology, 2017, 32(07): 1062-1064.
[10]Yuan Lixia, Zhang Ling, Zhang Qinglu, et al. Application Value of Combined Detection of CYFRA21-1, CA153, SCC, and CRP in
the Diagnosis of Lung Cancer[J]. Clinical Medicine Research and Practice,2022,7(01):122-125.DOI: 10.19347/j.cnki.2096-1413.202201031.
[11]Jiang Yuke, Li Changyi. Application of Novel Inflammatory Markers in Lung Cancer [J]. Modern Medical Health, 2024, 40(01):
111-116+121.
[12]Zhu Xuhua, Xie Yufen, Shi Xiaoyan, et al. Study on the diagnostic efficacy of blood NLR, PLR, and LMR detection in elderly patients with lung cancer[J]. Geriatrics & Health Care, 2023, 29(05): 954-959+963
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.
